14 results
Keyword Maalox Reflusso Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Tivicay
dolutegravir, HIV Infections
Date of authorisation: 16/01/2014, Revision: 34, Authorised, Last updated: 14/08/2023 -
List item
Human medicine European public assessment report (EPAR): Quinsair
levofloxacin, Cystic Fibrosis; Respiratory Tract Infections
Date of authorisation: 25/03/2015,
, Revision: 15, Authorised, Last updated: 22/12/2022
-
List item
Human medicine European public assessment report (EPAR): Crysvita
Burosumab, Hypophosphatemia, Familial; Hypophosphatemic Rickets, X-Linked Dominant; Osteomalacia
Date of authorisation: 19/02/2018,
, Revision: 11, Authorised, Last updated: 06/07/2023
-
List item
Human medicine European public assessment report (EPAR): Cerdelga
eliglustat, Gaucher Disease
Date of authorisation: 19/01/2015,, , Revision: 16, Authorised, Last updated: 28/08/2023
-
List item
Human medicine European public assessment report (EPAR): Onglyza
Saxagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 30/09/2009, Revision: 22, Authorised, Last updated: 21/04/2023 -
List item
Human medicine European public assessment report (EPAR): Isentress
Raltegravir, HIV Infections
Date of authorisation: 19/12/2007,
, Revision: 42, Authorised, Last updated: 20/10/2022
-
List item
Human medicine European public assessment report (EPAR): Revatio (updated)
sildenafil, Hypertension, Pulmonary
Date of authorisation: 28/10/2005, Revision: 50, Authorised, Last updated: 20/11/2023 -
List item
Human medicine European public assessment report (EPAR): Qtern
Saxagliptin, dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2; Diabetes Mellitus; Nutritional and Metabolic Diseases; Metabolic Diseases; Glucose Metabolism Disorders
Date of authorisation: 15/07/2016, Revision: 11, Authorised, Last updated: 30/05/2023 -
List item
Human medicine European public assessment report (EPAR): Adempas
riociguat, Hypertension, Pulmonary
Date of authorisation: 27/03/2014, Revision: 13, Authorised, Last updated: 31/08/2023 -
List item
Human medicine European public assessment report (EPAR): Conbriza
bazedoxifene, Osteoporosis, Postmenopausal
Date of authorisation: 17/04/2009, Revision: 15, Authorised, Last updated: 23/03/2021 -
List item
Human medicine European public assessment report (EPAR): Xeloda
capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 02/02/2001, Revision: 30, Authorised, Last updated: 26/10/2022 -
List item
Human medicine European public assessment report (EPAR): Dexxience
betrixaban maleate, Venous Thromboembolism
Date of refusal: 20/09/2018, Refused, Last updated: 09/10/2018 -
List item
Withdrawn application: Garenoxacin mesylate
date of withdrawal: 25/07/2007, Initial authorisation, Last updated: 26/07/2007 -
List item
Public data from Article 57 database
Last updated: 09/10/2023